Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

Approval of hypomethylating agents in patients with chronic myelomonocytic leukaemia is based on trials done in patients with myelodysplastic syndromes. We aimed to investigate whether hypomethylating agents provide a benefit in subgroups of patients with chronic myelomonocytic leukaemia compared wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet. Haematology 2021-02, Vol.8 (2), p.e135-e148
Hauptverfasser:	Pleyer, Lisa, Leisch, Michael, Kourakli, Alexandra, Padron, Eric, Maciejewski, Jaroslaw Pawel, Xicoy Cirici, Blanca, Kaivers, Jennifer, Ungerstedt, Johanna, Heibl, Sonja, Patiou, Peristera, Hunter, Anthony Michael, Mora, Elvira, Geissler, Klaus, Dimou, Maria, Jimenez Lorenzo, Maria-José, Melchardt, Thomas, Egle, Alexander, Viniou, Athina-Nora, Patel, Bhumika Jayantibhai, Arnan, Montserrat, Valent, Peter, Roubakis, Christoforos, Bernal del Castillo, Teresa, Galanopoulos, Athanasios, Calabuig Muñoz, Marisa, Bonadies, Nicolas, Medina de Almeida, Antonio, Cermak, Jaroslav, Jerez, Andrés, Montoro, Maria Julia, Cortés, Albert, Avendaño Pita, Alejandro, Lopez Andrade, Bernardo, Hellstroem-Lindberg, Eva, Germing, Ulrich, Sekeres, Mikkael Aaron, List, Alan Francis, Symeonidis, Argiris, Sanz, Guillermo Francisco, Larcher-Senn, Julian, Greil, Richard
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents - therapeutic use Azacitidine - therapeutic use Female Humans Hydroxyurea - therapeutic use Kaplan-Meier Estimate Leukemia, Myelomonocytic, Chronic - diagnosis Leukemia, Myelomonocytic, Chronic - drug therapy Leukemia, Myelomonocytic, Chronic - mortality Male Middle Aged Prognosis Proportional Hazards Models Retrospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!